FCF Fox Company Finance GmbH is delighted to publish the brand new “FCF Life Sciences Enterprise Capital Monitor – Europe 11/2021”.
The Monitor is a month-to-month printed overview of enterprise capital traits within the European Life Sciences sector.
As of the tip of November 2021 we establish the next present VC traits in Europe:
- In 2021, general Life Sciences funding has reached EUR 12,769m to date
- High 5 Offers exceed EUR 200m every, largest transaction amounted to EUR 497m in CMR Surgical Ltd. (United Kingdom)
- BlackRock (USA) nonetheless dominates the High 5 Buyers (by deal quantity), adopted by Constancy Administration & Analysis (USA) and Sofinnova Companions (France)
- The MedTech sector obtained 37% of the overall funding quantity (+7% factors in comparison with the earlier month)
- Oncology dominates as the highest indication of the Biotechnology sector
To entry the total report, please click on right here.
By Dr. Mathias Schott and Sebastian Sommer